Dzina la Mankhwala: (R) -4-Benzyl-2-Oxazolidinone
Mawu ofanana: R-BOZ
CAS: 102029-44-7
Maonekedwe: Ufa Woyera
Kuyera: ≥98.0% (HPLC)
Pakati pa Aliskiren ndi Aliskiren Hemifumarate
E-mail: alvin@ruifuchem.com
Dzina la Mankhwala: (S) -4-Benzyl-2-Oxazolidinone
Mawu ofanana: S-BOZ
CAS: 90719-32-7
Maonekedwe: Makristalo Oyera mpaka Oyera
Kuyera: ≥99.0% (HPLC)Chiral Purity: ≥99.5% (GC)
Inquiry: alvin@ruifuchem.com
Dzina la Mankhwala: (S)-(+)-4-Phenyl-2-Oxazolidinone
CAS: 99395-88-7
Maonekedwe: Ufa Woyera kapena Woyera wa Crystalline
Kuyera: ≥99.0% (HPLC)
Chiral Purity: ≥99.0% (GC)
Pakati pa Ezetimibe (CAS: 163222-33-1) pochiza hypercholesterolemia
Dzina: (R)-(-)-3-Aminopiperidine Dihydrochloride
CAS: 334618-23-4
Maonekedwe: Choyera Cholimba
Kuyera: ≥99.0% (HPLC)Kuwala Kwambiri: ee ≥99.0%
Chiral Compounds, Commercial Production
Dzina Lamankhwala: (R)-(-)-α-Methoxyphenylacetic Acid
CAS: 3966-32-3
Maonekedwe: Ufa Woyera-Woyera
Isomer: ≤0.5%
Dzina Lamankhwala: (S)-(-)-4-Chloro-3-Hydroxybutyronitrile
CAS: 127913-44-4
Maonekedwe: Zamadzimadzi Zopanda Mtundu mpaka Kuwala Zachikasu
Chiyero: ≥98.0%
Chinyezi (KF): ≤0.50%
Chiral Compounds, High Quality, Commercial Production
Dzina Lamankhwala: (S)-(+)-Glycidyl Phthalimide
CAS: 161596-47-0
Maonekedwe: Ufa Woyera mpaka Woyera
Pakati pa Rivaroxaban (CAS: 366789-02-8) pochiza Venous Thromboembolism (VTE)
Dzina Lamankhwala: (S) -3-Hydroxypyrrolidine Hydrochloride
CAS: 122536-94-1
Maonekedwe: Oyera-Woyera mpaka Brown Crystalline Powder
Kuyera: ≥98.0% (GC)
Pakati pa Darifenacin Hydrobromide (CAS 133099-07-7) pochiza chikhodzodzo chochuluka
Dzina Lamankhwala: (R)-(-)-3-Pyrrolidinol Hydrochloride
CAS: 104706-47-0
Maonekedwe: Oyera-Woyera mpaka Pale Brown Crystalline Ufa
Kuyera: ≥ 99.7% (GC)
Chiral Purity: ≥ 99.7% ee
Pakati pa Panipenem (CAS 87726-17-8) ndi Darifenacin hydrobromide (CAS 133099-07-7)
Dzina Lamankhwala: (S) -3-Hydroxytetrahydrofuran
CAS: 86087-23-2
Colerless Transparent to Light Yellwow Liquid
Chiyero: >99.0%(GC) Kuyera Kwambiri:>99.0% (GC)
Pakati pa Afatinib, Amprenavir, Fosamprenavir